icon covid

Zero Contact™ At-Home Saliva COVID-19 Test

FDA-EUA Authorized

Includes FedEx Overnight Shipping to the Lab and an official lab report.

$99 For Health Care Professionals Only

How It Works

ico step1 order

Step 1: Order Test Kits

Order tests in bulk for your patients. You charge your patients via Cash, HSA, or FSA for the tests and are responsible for getting the test to your patient.

ico step2 register

Step 2: Register Your Patient’s Test Kit

You or your patient registers the kit. Your office will be faxed results as long as you or your patient enter your office’s fax number during the registration process.

ico step3 sample

Step 3: Patients Collect Their Samples

The patient takes the test. Then they send it to the lab using the included shipping return mailer.


ico step4 results

Step 4: Receive Results

Once the lab receives the sample, patients will get their test results and recommendations within 48 hours through our online system.

FDA Emergency Use Authorized
At-Home Saliva COVID-19 Test

Our self-collection testing kit for COVID-19 uses a hassle-free saliva sample to determine if your patients are infected with the SARS-CoV-2 virus. We’ve partnered with labs operating under the Emergency Use Authorization guidelines issued by the FDA.

Our test kits include a complimentary overnight return mailer for sending the sample to the lab. Within 48 hours of the lab receiving the sample, patients will be able to access their results in our online system. If the result is positive, ordering physician needs to report to the appropriate authorities.

Collection Method:
Saliva Collection Tube

Digital Results Available Within:
48 hours of the lab receiving the sample

FDA Authorization

This test has been authorized by the FDA under an Emergency Use Authorization for use by authorized laboratories. This test has not been FDA cleared or approved. This test has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. This test is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.